COMP <GO>
EPAM vs DOX // EV/EBITDA & P/E VALUATION
EPAM Systems Inc. (NYSE) VS. Amdocs Limited (NASDAQ) • 15-METRIC TALLY: EPAM 4
— DOX 9
▲ EV/EBITDA & P/E VALUATION LEADER: DOX
LAST: $140.51 (+4.31%) • MKT CAP: $6.95B
valuation
10.2x
LAST: $62.83 (+0.98%) • MKT CAP: $6.72B
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPAM VS. DOX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPAM | DOX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.80% | 35.10% | -6.30 | DOX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | 23.60% | -6.50 | DOX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.2x | 9.7x | +0.50 | DOX | /valuation <GO> |
| Free Cash Flow Yield | 8.82% | 9.21% | -0.39 | DOX | /fcf-yield <GO> |
| Operating Margin | 9.50% | 12.60% | -3.10 | DOX | /operating-margins <GO> |
| Net Profit Margin | 6.90% | 9.90% | -3.00 | DOX | /net-margins <GO> |
| Revenue Growth (YoY) | 15.40% | 2.40% | +13.00 | EPAM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 3.16% | -3.16 | DOX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.67 | 4.98 | +0.69 | EPAM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.4 | 58.0 | +3.40 | EPAM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.37 | 1.39 | -0.02 | DOX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.5x | 12.6x | +2.90 | DOX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.95B | $6.72B | $232.1M | EPAM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPAM REV | DOX REV | EPAM GROSS % | DOX GROSS % | EPAM FCF | DOX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.46B | — | 28.8% | — | $612.7M | — |
| FY 2024 | $4.73B | $5.00B | 30.7% | 35.1% | $527.0M | $618.9M |
| FY 2023 | $4.69B | $4.89B | — | — | $351.6M | $602.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPAM // BETA 1.37
DOX // BETA 1.39